Mallinckrodt Plc () News - MNKKQ | ADVFN

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
USOTC
Mallinckrodt Plc () (MNKKQ)
Mallinckrodt Plc () (MNKKQ) News

Mallinckrodt Plc () (MNKKQ)

0.02

0.00

(0.00%)

Closed July 30 4:00PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

FeaturedELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES

FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

College Business & Technology Park false 0001567892 --12-30 0001567892 2022-06-15 2022-06-15 UNITED STATES SECURITIES AND...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on June 17, 2022 No. 333-189711 No. 333-189712...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on June 17, 2022 No. 333-189711 No. 333-189712...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on June 17, 2022 No. 333-189711 No. 333-189712...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on June 17, 2022 No. 333-189711 No. 333-189712...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on June 17, 2022 No. 333-189711 No. 333-189712...

Mallinckrodt Resubmits Application for Terlipressin in Hepatorenal Syndrome

By Michael Dabaie Biopharmaceutical company Mallinckrodt PLC said it resubmitted its new drug application to the U.S. Food and Drug Administration...

20BaggerDeluxe

20BaggerDeluxe 4 years ago

There might be a chance they can restructure and leave the opioid crisis behind. They were involved with billion dollar companies not too long ago. I am hoping an investment firm can scoop them up and turn them around on the cheap

Mallinckrodt ()

Viveon Health Acquisition

Seoul in Bioscience

Delayed Upgrade Clock